Nuvisan

🎄✨ Season’s Greetings from NUVISAN! ✨🎄 As the year draws to a close, we want to express our heartfelt gratitude to our partners, clients, and team members for an incredible year of collaboration and innovation. May this holiday season bring joy, warmth, and success to you and your loved ones. Here’s to an inspiring and prosperous New Year! Shoutout to Vera Schütz and the Chemistrylab for keeping our tradition of the NUVISAN Chemistree alive year after year! 🎁 Together, let’s continue making a difference in 2025! Happy Holidays – From the NUVISAN Team

💥 We are delighted to announce that NUVISAN France has officially received accreditation for the Tax Research Credit (Crédit d’Impôt Recherche - CIR) for 2024-2026. This accreditation highlights our unwavering dedication to fostering innovation and advancing research and development in the fields we serve. A heartfelt thank you to our incredible teams and collaborators for their hard work and contributions to this milestone. We also extend our gratitude to the French Ministry of Higher Education and Research for their thorough review and approval of our dossier. 🤝 NUVISAN: Your trusted Partner in bringing Therapeutics to life! #NUVISAN #ScienceCRO #drugdevelopment #drugdiscovery #France #CIR #accreditation

🧬 Step into the World of Life Science Chemistry at NUVISAN – Virtually! We are excited to share the first part of our virtual tour through our Life Science Chemistry facilities in Berlin. Take a closer look at: • Preparative Chemistry • High-Pressure Technologies • Microbiological Chemistry • Purification Services • Building Block Collection • Logistics & International Trade Compliance 🚀 Explore the tour to see how we can support your research: https://lnkd.in/dwpyiEG5 Reach out to our experienced team today, we are looking forward to collaborating with you: https://lnkd.in/eCuFudHJ #NUVISAN #LifeScience #Chemistry #MedChem #DiscoveryResearch #Labtour #Berlin

🤝 Register for the First-Ever AGM Workshop in Europe! We are pleased to announce that NUVISAN is co-organizing the Assay Guidance Workshop for High-Throughput Screening and Lead Discovery in collaboration with the National Center for Advancing Translational Sciences (NCATS), EATRIS, and EU-OPENSCREEN. ⏰ When: April 9-10, 2025 📍 Where: NUVISAN Berlin site The two-day workshop will cover a broad range of critical concepts underlying assay development and implementation for high-throughput screening and lead discovery projects presented by leading experts in the HTS space. On the third day, you’re invited to an exclusive tour of our state-of-the-art drug discovery facility at NUVISAN Berlin. Discover how our scientists drive innovation in biochemical and cell-based assay development, high-content analysis, HTS, hit-to-lead, and lead optimization projects. This workshop is free, but spaces are limited! 🎯 Secure your spot now: https://lnkd.in/dSmisTge #screening #drugdiscovery #AGMWorkshop #NUVISAN #ScienceCRO

💡 It was a pleasure meeting all of you at the Protein Structure Determination in Industry Meeting last month. We hope you found the meeting and our conversations insightful! 📃 If you missed the opportunity to view our poster, Structural Biology Platform at Nuvisan Berlin, during the conference, don’t worry - it is now available online: https://lnkd.in/dzUNEK9a Nuvisan provides an integrated protein production pipeline, covering everything from gene cloning to purification, to delivering high-quality recombinant proteins essential for structural biology. Our state-of-the-art structural biology services platform supports drug discovery projects using advanced techniques like X-ray crystallography, cryo-EM, and NMR. Would you like a detailed discussion? Feel free to connect with our scientist Simon Holton. #StructuralBiology #ProteinProduction #DrugDiscovery #NUVISAN #ScienceCRO

💊 Advance Your Drug Development Initiatives with Our Exclusive Year-End Offer! 🔍 Are you in search of a trusted and experienced partner for your DMPK studies? With over 40 years of expertise, we deliver reliable, timely data with unparalleled flexibility, providing robust support for the development of safe and effective pharmaceuticals. For detailed information about our limited-time offer, please contact Dr. Natascha Ihbe. This offer is valid until January 15, 2025. Reach out today to secure your opportunity! Why work with NUVISAN? - Proven Expertise: Our team of experienced scientists provides exceptional PK studies. - Rapid Turnaround: Accelerate your drug development timeline.  - Data-Driven Insights: Uncover valuable insights to optimize your drug candidate. - Highest standards for animal care and use: NUVISAN is AAALAC-accredited. #DMPK #SmallMolecules #InVivo #PKStudies #NUVISAN #ScienceCRO

👏 The NUVISAN 3rd Venture Capital Forum was nothing short of inspiring! Hearing global venture capital firms share their experiences in company creation and witnessing innovative company pitches was truly energizing. As a science CRO, we take great pride in connecting biotech with venture capital and driving innovation in the biopharma industry. We can’t wait to see you at the 4th NUVISAN Venture Capital Forum next year! #VentureCapital #networking #biotech #NUVISAN #ScienceCRO

📯 Did you miss the opportunity to view the poster 'Methods for Characterization and Derisking of Small Molecule Hits and Leads: Learnings from RAS-SOS1 and Hippo Pathway Screens' presented by Benjamin Bader at ELRIG Drug Discovery 2024? This poster is now live: https://lnkd.in/e_6pZT4R 👀 View it to gain insights into successful biochemical and cell-based pathway screening. Feel free to connect with Benjamin Bader for further discussions. #ELRIG #Biochemical #CellBasedHTS #HighthroughputScreening #ScienceCRO #NUVISAN

We are excited to be part of the vibrant AI-Healthcare-Community in Berlin meeting today at the Ludwig Erhard Haus 🎉 Our Head of Digital Life-Sciences, Franz von Nussbaum, will deliver a presentation titled “AI in Industrial Drug Research: Current Developments and Challenges” at 16:15.   Digital Technologies and AI revolutionize drug discovery & development—accelerating processes, reducing costs, and speeding-up market entry.  At Nuvisan we are building a fully integrated digital drug discovery unit helping clients from pharma companies, biotechs and academia to have flexible access to these technologies, supporting them on their journey to discover and develop new drugs for patients. Join Franz von Nussbaum’s talk to learn more about the practical applications of AI at NUVISAN. Can’t attend? No worries—connect with Franz von Nussbaum on LinkedIn to continue the conversation!   #DigitalLifeScience #DigitalDrugDiscovery #LifeScienceChemistry #NUVISAN #ScienceCRO #AI #Berlin  

📢 We are at the 17th EBF Open Symposium Are you attending the 17th EBF Open Symposium in Barcelona? We will be exhibiting through Friday. Our scientists and business development colleagues Achim Freisleben, Aude Février, Dr. Saskia Köcher, and Michaela Golob look forward to connecting with you and exploring potential collaborations for your bioanalytical projects! Don't miss the insightful talks by our scientists, Katja Zeiser and Dr. Hanna Widmaier today: • Katja Zeiser will present ‘Nuvisan ChatGPT – Artificial Intelligence in a (Regulated) Bioanalytical Laboratory of a CRO’ from 9:25 to 9:50. • Dr. Hanna Widmaier will share a case study on lessons learned from the transfer and validation of an ex-vivo neutrophil activation assay, from 15:30 to 15:50. #Bioanalysis #DrugDevelopment #NUVISAN #ScienceCRO